Dublin, March 27, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Ablation Devices Global Market - Forecast to 2023" report to their offering. The ablation device global market is expected to grow at high single digit CAGR to reach $20,995.5 million by 2023.
The ablation device global market by technology is segmented into thermal ablation and non thermal ablation. The thermal ablation technologies are radiation therapy, cryoablation, radiofrequency, laser, ultrasound, microwave, and hydrothermal ablation technology. Among thermal ablation, radiofrequency ablation accounted for the largest share in 2016 and microwave is expected to grow at highest CAGR from 2016-2023. Non thermal technology includes electroporation, mechanical ablation and others (Chemical). Among non thermal ablation technologies, electroporation generated the largest share in 2016, and is expected to grow at a mid single digit CAGR from 2016-2023. By application, the ablation device global market is segmented oncology, cardiovascular diseases, ophthalmology, cosmetology, gynaecology, general surgery, urology, orthopaedics, pain management and others. Atrial Fibrilation, Ventricular Tachycardia and Others are the segments in cardiovascular application. Oncology is holding the largest revenue in 2016 and cardiovascular application is expected to grow at a high CAGR from 2016-2023. By end-users, the market is segmented into hospitals, ambulatory surgical centres and speciality clinics. Hospitals generated the largest revenue in 2016 and are expected to grow at high CAGR from 2016-2023. By geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America holds the largest market share in 2016, followed by Europe and Asia. The APAC regions tend to be an emerging market with an opportunity for growth with a highest CAGR from 2016-2023 and are likely to be a destination of investment for new investors in the ablation device market. The ablation device market is expected to grow at high single digit CAGR from 2016-2023. The major factor influencing the growth are increasing number of ablation procedures, rising incidence of cancer, emergence of next-generation ablation products and technologies, growing adoption of minimally invasive procedures, and improving reimbursement scenario in established markets are some of the factors driving the market. However, reuse and reprocessing of devices in developing countries, healthcare cost-containment measures, stringent regulatory guidelines, and challenges in therapeutic procedures are some of the factors hampering the market. The key players in the ablation device global market include
- Boston Scientific Corporation (U.S.)
- Johnson and Johnson (U.S.)
- Abbott laboratories (St Jude Medical) (U.S.)
- Medtronic (Ireland)
- Stryker Corporation (U.S.)
- Elekta AB (Sweden)
- Olympus Corporation (Japan)
- ConMed Corporation (U.S.)
- Hologic (U.S.)
- Articure Inc. (U.S.)
- Angiodynamics Inc. (U.S.)
- Smith and Nephew plc (U.K.)
- Varian Medical Systems (U.S.).
Market Analysis: Factors Influencing Market
Drivers and Opportunities
- Increasing Aging Population
- Rising Incidence of Cancer and Cardiovascular Diseases
- Growing Adoption of Minimally Invasive Procedures
- Improving Reimbursement Scenario in Established Markets
- Emergence of Next-Generation Ablation Products and Technologies
- Increasing Number of Ablation Procedures
- Increasing Funding for the Development of Novel Ablation Device
- Emerging Apac Markets
Restraints & Threats
- Reuse and Reprocessing of Devices in Developing Countries
- Healthcare Cost Containment Measures
- Stringent Regulatory Approvals
- Challenges in Therapeutic Procedures
Companies Mentioned
- Abbott Laboratories
- Access Point Technologies
- Accuray
- Aishen Medical Technologies
- Alcon Research
- Alma
- Alpinion Medical Systems
- Angiodynamics Inc.
- Apama Medical
- Apro Korea
- Aquilant Medical
- Arthrex
- Articure Inc.
- Avinger
- Baylis Medical
- Best Nomos
- Biolitec AG
- Biotronik
- Boston Scientific Corporation
- Bovie Medical
- Brainlab Inc.
- BTG Plc
- C.R. Bard
- Cardima Inc
- Cardiofocus., Inc.
- Cardiosonic
- Cardiovascular Systems Inc
- Carl Zeiss
- Catheffects Llc
- Catheter Robotics
- Chongqin Haifu Technology Co. Ltd
- Conmed Corporation
- Convergent Laser Technologies
- Cooltouch
- Cooper Surgical
- CSA Medical
- Curon Medical, Inc.
- Cynosure
- Diros Technology
- Dornier Medtech
- EDAP TMS
- Elekta
- Emblation Microwave
- Endotherapeutics
- EV3 Inc
- Eye Tech Care
- Fcare Systems
- Focusstart
- FUS Instruments
- GE Medical Systems
- Hansen Medical
- Haylard Health
- Hologic
- HS Medical Inc.
- Imricor Medical Systems
- Insightec
- Ion Beam Applications SA
- Japan Lifeline
- Jena Surgical
- Johnson and Johnson
- Khelix Medical
- Lepu Medical
- Lumenis Ltd
- Medispec
- Medlumics
- Medtronic
- Medwaves
- Microsurgeon Inc.
- Minerva Surgical
- Misonix
- Monteris Medical
- Nanospectra Biosciences
- Neolaser
- Neusoft Medical Systems
- Nidek Co Ltd
- Olympus Corporation
- Omeicos Therapeutics
- Panacea Medical Technologies
- Pentax Medical
- Perseon Corporation
- Philips
- Profound Medical
- Prostalund AB
- Pyrexar Medical
- Recor Medical
- Relievant Medsystems
- RF Medical Co., Ltd.
- Schwind Eye Tech Solutions
- Shenzen Hyde Medical Equipment
- Shinva Medical
- Smith and Nephew Plc
- Sonacare Medical
- Sonic Concepts Inc
- Spectranetics
- Stereotaxis
- Stryker Corporation
- Symple Surgical Inc.
- Taewoong Medical
- Theraclion
- Theralase
- Trod Medical
- United Medical Systems
- Urologix
- Varian Medical Systems
- Visx Inc
- Vivant Medical
- Wikkon Medical
- Wontech
- Ziemer Group
For more information about this report visit http://www.researchandmarkets.com/research/nh...on_devices
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Surgical Devices
